Carbinoxamine maleate 0.8 mg/mL / dextromethorphan hydrobromide 2.5 mg/mL / pseudoephedrine hydrochloride 12 mg/mL Oral Solution
RxNorm 1012984
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012984 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine maleate 0.8 mg/mL / dextromethorphan hydrobromide 2.5 mg/mL / pseudoephedrine hydrochloride 12 mg/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine maleate 0.8 mg/ML / dextromethorphan hydrobromide 2.5 mg/ML / pseudoephedrine hydrochloride 12 mg/ML Oral Solution
(Atom ID: 12331130)
PSN
Prescribable Name (PSN):
Carbinoxamine maleate 0.8 mg/mL / dextromethorphan hydrobromide 2.5 mg/mL / pseudoephedrine hydrochloride 12 mg/mL Oral Solution
(Atom ID: 11839809)
SY
Synonym (SY):
Carbinoxamine maleate 4 mg / dextromethorphan hydrobromide 12.5 mg / pseudoephedrine hydrochloride 60 mg per 5 mL Oral Solution
(Atom ID: 3621617)
PT
Designated preferred name (PT):
Carbinoxamine maleate 800 microgram/mL and dextromethorphan hydrobromide 2.5 mg/mL and pseudoephedrine hydrochloride 12 mg/mL oral solution
(Atom ID: 11435713)
FN